 |
|
|
|
|
Utah Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Myriad Pharmaceuticals, Inc.
| | | | | Phone: | (800) 4-MYRIAD | | Fax: | (800) 469-7423 | | Year Established: | 1991 | | Employees: | 200 | | Ticker: | MYGN | | Exchange: | NASDAQ | | Main Contact: | Mark C. Capone, President & CEO | | | | Other Contacts: | Robert G. Harrison, CIO
Patrick Burke, Executive VP, Emerging Products
Gary A. King, Executive VP, International Operations
Johnathan M. Lancaster, CMO
Jerry Lanchbury, CSO
Richard Marsh, Executive VP & General Counsel
| | | | Company Description | | Myriad Genetics is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on five strategic imperatives: build upon a solid hereditary cancer foundation, growing new product volume, expanding reimbursement coverage for new products, increasing RNA kit revenue internationally and improving profitability with Elevate 2020. | |
|
|
|
|
|
|
|
